STOCK TITAN

Dexcom to Present at 43rd Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

DexCom (NASDAQ:DXCM) has announced its upcoming participation at the 43rd Annual J.P. Morgan Healthcare Conference. The company's management will deliver a corporate update presentation on January 13, 2025, at 12:00 PM EST.

The presentation will be accessible through a live webcast, with links available on the Dexcom Investor Relations website at investors.dexcom.com. For those unable to attend live, the presentation will be archived on the website for future viewing.

DexCom (NASDAQ:DXCM) ha annunciato la sua prossima partecipazione alla 43ª Conferenza Annuale J.P. Morgan Healthcare. La direzione dell'azienda fornirà una presentazione di aggiornamento aziendale il 13 gennaio 2025, alle 12:00 PM EST.

La presentazione sarà disponibile tramite una diretta streaming, con i link accessibili sul sito delle Relazioni con gli Investitori di Dexcom all'indirizzo investors.dexcom.com. Per coloro che non possono partecipare dal vivo, la presentazione sarà archiviata sul sito per una visione futura.

DexCom (NASDAQ:DXCM) ha anunciado su próxima participación en la 43ª Conferencia Anual de Atención Médica de J.P. Morgan. La dirección de la empresa ofrecerá una presentación de actualización corporativa el 13 de enero de 2025, a las 12:00 PM EST.

La presentación será accesible a través de una transmisión en vivo, con enlaces disponibles en el sito de Relaciones con Inversionistas de Dexcom en investors.dexcom.com. Para aquellos que no puedan asistir en vivo, la presentación se archivará en el sitio para futuras visualizaciones.

DexCom (NASDAQ:DXCM)제43회 JP모건 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회사 경영진은 2025년 1월 13일 정오 12:00 PM EST에 기업 업데이트 발표를 진행할 예정입니다.

발표는 실시간 웹캐스트를 통해 이용 가능하며, 링크는 Dexcom 투자자 관계 웹사이트인 investors.dexcom.com에서 확인할 수 있습니다. 실시간 참석이 불가능한 분들을 위해 발표는 향후 시청을 위해 웹사이트에 보관될 것입니다.

DexCom (NASDAQ:DXCM) a annoncé sa prochaine participation à la 43ème Conférence Annuelle J.P. Morgan Healthcare. La direction de l'entreprise présentera une mise à jour de la société le 13 janvier 2025 à 12h00 EST.

La présentation sera accessible via un webinaire en direct, avec des liens disponibles sur le site des Relations Investisseurs de Dexcom à l'adresse investors.dexcom.com. Pour ceux qui ne peuvent pas assister en direct, la présentation sera archivée sur le site pour une consultation future.

DexCom (NASDAQ:DXCM) hat seine bevorstehende Teilnahme an der 43. J.P. Morgan Healthcare-Konferenz angekündigt. Das Management des Unternehmens wird am 13. Januar 2025 um 12:00 Uhr EST eine Unternehmenspräsentation geben.

Die Präsentation wird über einen Live-Webcast zugänglich sein, mit Links, die auf der Dexcom Investor Relations-Website unter investors.dexcom.com verfügbar sind. Für diejenigen, die nicht live teilnehmen können, wird die Präsentation auf der Website zur späteren Ansicht archiviert.

Positive
  • None.
Negative
  • None.

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the 43rd annual J.P. Morgan Healthcare Conference on January 13, 2025.

The live presentation is scheduled to begin at approximately 12:00 PM EST and will be concurrently webcast.

Links to the webcast will be available on the Dexcom Investor Relations website at investors.dexcom.com and will be archived there for future reference.

About DexCom, Inc.

Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.

Dexcom. Discover what you’re made of. For more information, visit www.dexcom.com.

Category: IR

DexCom, Inc.

Sean Christensen

Vice President – Finance and Investor Relations

investor-relations@dexcom.com

(858) 200-0200

Source: DexCom, Inc.

FAQ

When is Dexcom (DXCM) presenting at the J.P. Morgan Healthcare Conference 2025?

Dexcom (DXCM) is scheduled to present at the J.P. Morgan Healthcare Conference on January 13, 2025, at 12:00 PM EST.

How can investors watch Dexcom's (DXCM) J.P. Morgan Healthcare Conference presentation?

Investors can watch the presentation through a live webcast available on Dexcom's Investor Relations website at investors.dexcom.com. The presentation will also be archived for future viewing.

What will be discussed at Dexcom's (DXCM) J.P. Morgan Healthcare Conference presentation?

Management will present a company update at the conference, providing information about Dexcom's current status and developments.

Will Dexcom's (DXCM) J.P. Morgan Healthcare Conference presentation be available for replay?

Yes, the presentation will be archived on Dexcom's Investor Relations website at investors.dexcom.com for future reference.

DexCom, Inc.

NASDAQ:DXCM

DXCM Rankings

DXCM Latest News

DXCM Stock Data

31.40B
389.05M
0.31%
97.03%
2.39%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
SAN DIEGO